Læknaneminn - 01.04.1988, Qupperneq 30

the relaxation of arterial smooth muscle
by actylcholine. Nature. 288, 373-376
(1980).
2. Jaffe.E.A. Ceil biology of
endothelial cells. HumanPathol. 18(3),
234-239(1987).
3. Furchgott.R.F. Pharmac.Rev. 7,183-
265 (1955).
4. Förstermann,U. Properties and
mechanism of production and action of
endothelium-derived relaxant factor.
J.Cardiovasc.Pharmac. 8(S 10), S45-
S51 (1986).
5. Peach.M.J., Loeb.A.L., Singer,H.A.
& Saye.J. Endotelium-derived relxant
factor. Hypertension. 7(3)(S1), 194-
1100(1985).
6. Vane.J.R., Gryglewski.R.J. &
Botting.R.M. The endothelial cell as a
metabolic and endocrine organ. TIPS.
8,491-496(1987).
7. Izzo,N.J., Loeb.A.L., Johns,R.A. &
Peach.M.J. Intracellular calcium flux
accompanies the release of endothelial
derived relaxing factor (EDRF) and
prostacyclin (PGI2) from cultured
endothelial cells.(abstract) Fed.Proc.
45(3), 198 (1986).
8. Halldórsson,H., Kjeld.M. &
Thorgeirsson,G. Role of
phosphoinositides in the regulation of
endothelial prostacyclin production.
Arterioscl. (í prentun) (1988)
9. Singer.H.A. & Peach.M.J.Calcium-
and endothelial-mediated vascular
smooth muscle relaxation in rabbit
aorta. Hypertension. 4(3)(SII), 1119-
1125 (1982).
10. Peach,M.J., Singer.H.A., Izzo,N.J.
& Loeb.A.L. Role of calcium in
endothelial-dependent relaxation of
arteial smooth muscle. Am.J.Cardiol.
59, 35A-43A (1987).
11. Long,C.J. & Stone,T.W. The
release of endothelium-derived
relaxant factor is calcium dependent.
Blood Vessels. 22, 205-208 (1985)
12. Liickhoff,a. & Busse.R. Increased
free calcium in endothelial cells under
stimulatin with adenine nucleotides.
J.Cell.Physiol. 126, 414-420 (1986)
13. White,D.G. & Martin.W.
Differential production of
endothelium-derived relaxant factor
and prostacyclin by pig aortic
endothelial cells.(abstract) Br.J.
Pharmac. 92, 520PG987).
14. Long,C.J., Sarau,H.M. &
Berkowitz,B.A. The inhbition of
release of endothelium-derived
relaxant factor by manoalide, a potent
inhibitor of phospholipase A2. Br.J.
Pharmac. 92, 843-849(1987)
15. Griffith,T.M„ Edwards.D.H.,
Lewis,M.J., Newby.A.C. &
Henderson.A.H. The nature of
endothelium-derived relaxant factor.
Nature. 308, 645-647 (1984).
16. Furchgott.R.F., Zawadzki.J.V.,
Jothianandan.D. & Cherry,P.D.
Nordihydroguiaretic acid (NDGA) and
dibromoacetophenone (BPB) inhibit
endothelium-dependant relaxation of
arteries by acetylcholine, bradykinin
and A23187.(abstr) Fed.Proc. 41,1233
(1982)
17. Berridge,M.J. & Irvine.R.F.
Inositol triphosphat, a novel second
messenger in signal transduction.
Nature. 317, 315-321 (1984).
18. Nishizuka.Y. Tumover inositol
phospholipids and signal transduction.
Science. 225, 1365-1370(1984).
19. Berridge.M.J. Inositol
trisphosphate and diacylglycerol: Two
interacting second messengers.
Ann.Rev.Biochem. 56, 159-93 (1987).
20. Haraldur Halldórsson. cfe
Guðmundur Þorgeirsson. Inósitóllípíð -
nýtt boðkerfi í frumum. Læknablaðið.
71,221-225 (1985).
21. Barnes,D.M. How cells respond to
signals. Science. 234, 286-288 (1986).
22. Irvine,R.F. & Moor,R.M. Micro-
injection of inositol 1,3,4,5-
tetrakisphosphate activates sea urchin
eggs by a mechanism dependent on
external Ca2+. Biochem.J. 240, 917-
920(1986).
23. Irvine.R.F. How is the level of free
arachidonic acid controlled in
mammalian cells? Biochem.J. 204, 3-
16 (1982)
24. Feinstein,F.B. & Shaafi.R.I. Roleof
calcium in arachidonic acid
metabolism and in the actions of
arachidonic acid-derived metabolites.
I: Cheung,W.Y.,ed. Calcium and cell
function, vol.IV, London: Academic
Press 1983,337-376.
25. Burgoyne.R.D.. Cheek.T.R. &
O'Sullivan.A.J. Receptor-activation of
phospholipase A2 in cellular
signalling. TIBS. 12, 332-333 (1987).
26. Needleman.P.. Turk.J.,
Jakschik,B.A„ Morrison,A.R. fe
Lefkowith,J.B. Arachidonic acid
metabolism. Ann.Rev.Biochem. 55,
69-102(1986).
27. Piomelli,D„ Volterra,A„ Dale,N„
Siegelbaum.S.A., Kandel.E.R.,
Schwartz,J.H. & Belardetti.F.
Lipoxygenase metabolites of
arachidonic acid as second messengers
for presynaptic inhibition of Aplysia
sensory cells. Nature. 328, 38-43
(1987).
28. Vanhoutte, P.M., Rubanyi.G.M.,
Miller,V.M. & Houston,D.S.
Modulation of vascular smooth muscle
contraction by endothelium.
Ann.Rev.Physiol. 48, 307-320 (1986).
29. Rapoport.R.M. & Murad,F.
Agonist-induced endothelium-
dependent relaxation in rat thoracic
aorta may be mediated through c-GMP.
Circ.res. 52, 352-357 (1983).
30. Waldman.S.A. & Murad.F. Cyclic
GMP synthesis and function.
Pharmac.Rev. 39(3) 163-196(1987).
31. Ignarro.L.J. & Kadowitz,P.J. The
pharmacological and physiological
role of C-GMP in vascular smooth
muscle relaxation. Ann.Rev.
Pharmac.Toxicol. 25, 171-191 (1985).
32. Houslay,M.D. Renaissance for
cyclic GMP? TIBS Dec.1985 465-466
(1985)
33. Radomski,M.W„ Palmer,R.M.J. &
Moncada,S. Comparative pharma-
cology of endothelium-derived
relaxant factor, nitric oxide and
prostacyclin in platelets. Br.J.Pharmac.
92, 181-187 (1987).
34. Furlong.B., Henderson,A.H„
Lewis.M.J. & Smith.J.A.
28
LÆKNANEMINN 1/1988-41. árg.